VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 121 filers reported holding VIKING THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 0.97 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $1,096,000 | +13.2% | 365,354 | +73.7% | 0.00% | – |
| Q4 2021 | $968,000 | -50.3% | 210,376 | -32.1% | 0.00% | -100.0% |
| Q3 2021 | $1,946,000 | +6.7% | 309,936 | +1.9% | 0.00% | 0.0% |
| Q2 2021 | $1,823,000 | +11.0% | 304,302 | +17.2% | 0.00% | 0.0% |
| Q1 2021 | $1,642,000 | +52.3% | 259,572 | +35.6% | 0.00% | 0.0% |
| Q4 2020 | $1,078,000 | +28.5% | 191,405 | +32.8% | 0.00% | 0.0% |
| Q3 2020 | $839,000 | -23.9% | 144,078 | -5.7% | 0.00% | 0.0% |
| Q2 2020 | $1,102,000 | +80.7% | 152,836 | +17.3% | 0.00% | 0.0% |
| Q1 2020 | $610,000 | -78.5% | 130,349 | -63.1% | 0.00% | -50.0% |
| Q4 2019 | $2,833,000 | +321.6% | 353,228 | +261.8% | 0.00% | +100.0% |
| Q3 2019 | $672,000 | -21.4% | 97,632 | -5.2% | 0.00% | 0.0% |
| Q2 2019 | $855,000 | -40.7% | 103,027 | -29.0% | 0.00% | 0.0% |
| Q1 2019 | $1,443,000 | -21.3% | 145,198 | -39.4% | 0.00% | -50.0% |
| Q4 2018 | $1,834,000 | -57.6% | 239,693 | -3.4% | 0.00% | -50.0% |
| Q3 2018 | $4,324,000 | +70.5% | 248,235 | -7.1% | 0.00% | +100.0% |
| Q2 2018 | $2,536,000 | +715.4% | 267,247 | +275.9% | 0.00% | – |
| Q1 2018 | $311,000 | – | 71,096 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| APIS CAPITAL ADVISORS, LLC | 148,000 | $1,638,360 | 2.12% |
| Sio Capital Management, LLC | 595,002 | $6,586,672 | 2.04% |
| 5AM Venture Management, LLC | 585,000 | $6,475,950 | 1.86% |
| Artia Global Partners LP | 383,580 | $4,246,231 | 1.76% |
| Integral Health Asset Management, LLC | 800,000 | $8,856,000 | 1.23% |
| Boxer Capital, LLC | 2,000,000 | $22,140,000 | 1.18% |
| DAFNA Capital Management LLC | 319,655 | $3,538,581 | 1.10% |
| Affinity Asset Advisors, LLC | 332,600 | $3,681,882 | 1.04% |
| MPM BioImpact LLC | 325,000 | $3,597,750 | 0.96% |
| Affinity Asset Advisors, LLC | 300,000 | $3,321,000 | 0.93% |